OncoBriefs - Oncology Research News

January 08, 2026

Neoadjuvant Chemotherapy With CAPOX vs. Chemoradiation for Rectal Cancer (CONVERT Trial)

Neoadjuvant Chemotherapy With CAPOX vs. Chemoradiation for Rectal Cancer (CONVERT Trial)

Every immune cell in your gut has been through boot camp. The mucosal lining of your rectum runs one of the toughest training programs in the body - a relentless gauntlet of bacterial invaders, dietary antigens, and the occasional rogue cell that forgot how to stop dividing. But when locally...

January 08, 2026

Neoadjuvant and Adjuvant Nivolumab with IRE for Liver Cancer

Neoadjuvant and Adjuvant Nivolumab with IRE for Liver Cancer

title: "The Double Agent in Your Liver: How Immunotherapy is Running Covert Ops Against Liver Cancer" slug: nivolumab-ire-nivolep-hcc date: 2026-04-15 tags: [hepatocellular carcinoma, immunotherapy, nivolumab, irreversible electroporation, ablation, NIVOLEP]

January 07, 2026

Nanozyme-Mediated PROTACs Delivery for Targeted Protein Degradation and Ferroptosis Sensitization in Prostate Cancer

Nanozyme-Mediated PROTACs Delivery for Targeted Protein Degradation and Ferroptosis Sensitization in Prostate Cancer

The cancer cells lost. Not just lost—they got outmaneuvered, outflanked, and then demolished by their own recycling machinery while simultaneously rusting from the inside out. That's the headline from a new study in Angewandte Chemie, where researchers essentially built a Trojan horse that sneaks...

January 07, 2026

Nationwide Mammographic Screening Among Transgender and Gender Diverse Individuals

Nationwide Mammographic Screening Among Transgender and Gender Diverse Individuals

You probably walked past a mammography clinic today, or at least an ad for one - those pastel-pink reminders plastered on bus stops and pharmacy bags telling you to "schedule your screening." But here's a question almost nobody thinks to ask: who are those reminders actually reaching, and who's...

January 06, 2026

January 06, 2026

Multiscale Mechanisms Driving Tissue Rupture by Invading Cells

Multiscale Mechanisms Driving Tissue Rupture by Invading Cells

Are you tired of your tissue barriers failing to keep out invasive cancer cells? Do your mesothelial linings crumble under the slightest pressure? Well, have we got the study for you! Except, plot twist - the barrier itself is partly to blame. A team of researchers just showed that when ovarian...

January 05, 2026

Look, We Need to Talk About Your Lab Mice

Look, We Need to Talk About Your Lab Mice

Researchers have spent decades watching mice get tumors, treating those tumors, and then publishing papers about it. There's just one small problem: about 92% of cancer drugs that work in mice fail spectacularly in human clinical trials. So either we've been curing mouse cancer really effectively,...

January 05, 2026

Math problem: 24 × 1 = a cure?

Math problem: 24 × 1 = a cure?

Twenty-four protein subunits. One hollow cage. That's all ferritin is - a tiny, self-assembling sphere your body already makes by the billions to store iron. Now multiply that simplicity by the sheer stubbornness of leukemia, where over 50% of patients relapse after CAR T cell therapy, and you've...

January 04, 2026

Liquid Biopsy: Finding Cancer With a Blood Draw Instead of a Scalpel

Liquid Biopsy: Finding Cancer With a Blood Draw Instead of a Scalpel

There is something deeply medieval about the traditional biopsy. You find a suspicious mass, stick a needle into it (or cut it out entirely), send the tissue to a lab, and wait. It works, but it is invasive, painful, limited to accessible tumors, and gives you a single snapshot of a single...

January 04, 2026

Location, Location, Location: When Your Pancreas Becomes a Bad Neighborhood

Location, Location, Location: When Your Pancreas Becomes a Bad Neighborhood

In real estate, they say it's all about location - and the same turns out to be true inside your body. Your pancreas, that unassuming little organ tucked behind your stomach, is normally a quiet residential district where hardworking acinar cells pump out digestive enzymes like clockwork. But when...

January 03, 2026

In Vivo Site-Specific Engineering to Reprogram...

In Vivo Site-Specific Engineering to Reprogram...

Right now, getting CAR-T cell therapy is a bit like ordering a bespoke suit that costs more than your house, takes weeks to tailor, and might not fit by the time it arrives. Doctors pull your T cells out, FedEx them to a specialized lab, genetically rewire them to hunt cancer, grow a few hundred...

January 03, 2026

Liquid Biopsy for Burkitt's Lymphoma: A Blood...

Liquid Biopsy for Burkitt's Lymphoma: A Blood...

Forty-seven days. That's roughly how long it takes to get a tissue biopsy diagnosis for Burkitt's lymphoma in East Africa. In the United States, the same process takes about two days. And Burkitt's lymphoma - the most common childhood cancer in equatorial Africa - is one of the fastest-growing...

January 02, 2026

Immunotherapy Combinations: Oncologists Are...

Immunotherapy Combinations: Oncologists Are...

Single-agent immunotherapy was a good start. Anti-PD-1 alone delivers durable responses in melanoma, lung cancer, and a handful of other tumor types. But for most cancers, monotherapy response rates hover in the 15-25% range, which means the majority of patients get the side effects without the...

January 01, 2026

Immune Cells Are Finally Hitting the Gym, and Cervical Cancer Is Getting Crushed

Immune Cells Are Finally Hitting the Gym, and Cervical Cancer Is Getting Crushed

Your immune system has been doing reps for years, but it took a little pharmaceutical personal training to really see results. Think of the HPV vaccine as the world's most effective workout plan for your immune cells - and the gains are finally showing up in the data.

January 01, 2026

Immunometabolic Gatekeeping: When Tissue Metabolism Plays the Bouncer for Tumor Immunity

Immunometabolic Gatekeeping: When Tissue Metabolism Plays the Bouncer for Tumor Immunity

Picture this: your immune system is like the bouncer at an exclusive club. Normally, it's pretty good at keeping out the unruly troublemakers, a.k.a. cancer cells. But what if the club itself is making it harder for the bouncer to do its job? That's exactly what researchers are exploring in the...

December 31, 2025

IL15-CIK Cells: When Your Immune System Gets a Startup-Style Upgrade

IL15-CIK Cells: When Your Immune System Gets a Startup-Style Upgrade

Pitch deck, slide one: "We're building a platform that takes underperforming security teams, supercharges them with a proprietary activation protocol, and deploys them directly into hostile environments to neutralize rogue actors - all with minimal collateral damage." Sounds like every Series A...

December 30, 2025

Fungal Genes Turn T Cells Into Sugar Smugglers...

Fungal Genes Turn T Cells Into Sugar Smugglers...

Somewhere in the evolutionary history of wood-rotting fungi, a pair of genes emerged that let mold eat trees. Millions of years later, a team at UCLA looked at those genes and thought: "What if we put these in immune cells to fight cancer?"

December 30, 2025

Going Once, Going Twice: Sold to the Red Blood Cell Carrying Cancer-Fighting Instructions

Going Once, Going Twice: Sold to the Red Blood Cell Carrying Cancer-Fighting Instructions

The auction house is open, and the hottest item on the block isn't a Picasso or a vintage Ferrari. It's your spleen. More specifically, scientists just figured out how to use your own red blood cells as delivery trucks to ship cancer-fighting instructions directly to immune cells hanging out in...

December 29, 2025

For a generation, we told ourselves cancer cells couldn't really do mitochondria.

For a generation, we told ourselves cancer cells couldn't really do mitochondria.

We were so proud of the Warburg effect - this tidy narrative that tumor cells ditch oxidative phosphorylation for quick-and-dirty glycolysis like college students living on ramen instead of cooking a proper meal. Textbooks printed it. Professors taught it. And while it wasn't exactly wrong, it was...